Episode notes
The roles of life sciences, pharma companies and those of data-technology companies have been orbiting around disease prevention, patient pathways, hospital delivery efficiencies and long-term care. Has the pandemic created a more conducive synergy. Where one starts and the other finishes shouldn’t really matter now, should it?
Keywords
the voices project
government
world health organisation
global policy
behaviour science
health policy
technology
medtech